Diagnostic Laboratories' Capacities and Preparedness for Emerging Viral Diseases in Guinea and Mali.
Diagnostic
Emerging Viral Diseases
Guinea
Mali
Preparedness
Journal
Infectious diseases diagnosis & treatment
ISSN: 2577-1515
Titre abrégé: Infect Dis Diagn Treat
Pays: United States
ID NLM: 101763328
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
17
9
2021
pubmed:
1
1
2020
medline:
1
1
2020
Statut:
ppublish
Résumé
The 2014-2016 Ebola epidemic in Guinea highlighted the need for more extensive evaluation of laboratories diagnostic capacities and preparedness in anticipation of future emerging viral disease outbreaks. We developed a questionnaire to assess the diagnostic capacities and preparedness of the four major medical laboratories in Guinea and Mali that are responsible for the provision of Ebola, Lassa, and Dengue diagnostics. The questionnaire inquired about the current state and need for equipment and reagents and adequacy of equipment and training received. In Guinea, all three diagnostic laboratories have the capacity and are well-prepared to perform Ebola diagnostics, however, only two have the capacity and trained staff to diagnose Lassa and none are currently prepared to diagnose Dengue infection. In Mali, the University Clinical Research Center (UCRC) laboratory, which was in charge of Ebola diagnostics during the last epidemic, currently has the capacity and is prepared to diagnose Ebola, Lassa, and Dengue infections. Combined, Guinea and Mali appear to have complementary capacity and preparedness to diagnose these Category A Priority Pathogens. While, the equipment, reagents and training efforts should be maintained, the gap in Dengue diagnostic capability in Guinea should be addressed with further equipping and training of additional district laboratories to strengthen the public health response for all viral diseases in these high-risk, yet, low-resource settings.
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : FIC NIH HHS
ID : D43 TW010350
Pays : United States
Organisme : FIC NIH HHS
ID : D71 TW010428
Pays : United States
Références
J Infect Dis. 2016 Oct 15;214(suppl 3):S164-S168
pubmed: 27707892
MMWR Suppl. 2016 Jul 08;65(3):4-11
pubmed: 27389903
Emerg Infect Dis. 2011 Aug;17(8):1349-54
pubmed: 21801609
Biosens Bioelectron. 2016 Jan 15;75:254-72
pubmed: 26319169
Viral Immunol. 2008 Jun;21(2):123-32
pubmed: 18476771
J Clin Microbiol. 2000 Jul;38(7):2670-7
pubmed: 10878062
PLoS Negl Trop Dis. 2009;3(3):e388
pubmed: 19255625
BMC Infect Dis. 2012 Sep 28;12:233
pubmed: 23020074
Pathog Glob Health. 2016 Jun-Jul;110(4-5):137-47
pubmed: 27315342
BMC Infect Dis. 2015 May 29;15:217
pubmed: 26022703
Infect Dis Ther. 2015 Dec;4(4):365-90
pubmed: 26363787
Clin Trials. 2016 Feb;13(1):73-8
pubmed: 26768557
J Clin Microbiol. 2010 Jun;48(6):2009-13
pubmed: 20351210
Curr Opin Virol. 2019 Aug;37:132-138
pubmed: 31518896
J Infect Dis. 2016 Oct 15;214(suppl 3):S169-S176
pubmed: 27333914
J Infect Dis. 2016 Oct 15;214(suppl 3):S203-S209
pubmed: 27521365
PLoS Negl Trop Dis. 2015 Mar 17;9(3):e0003631
pubmed: 25781465
J Clin Microbiol. 2001 Sep;39(9):3267-71
pubmed: 11526161